Literature DB >> 28849658

A Stereocontrolled Annulation of the Taccalonolide Epoxy Lactone onto the Molecular Framework of trans-Androsterone.

Jakob Danielsson1, Diana X Sun1, Xiao-Yang Chen1, April L Risinger2, Susan L Mooberry2, Erik J Sorensen1.   

Abstract

A robust and scalable route to the taccalonolide skeleton starting from trans-androsterone is presented. The synthesis features a cyclic hydroboration carbonylation reaction, which effectively establishes the trans-hydrindane DE ring junction in a remarkable annulation reaction, as well as a Claisen rearrangement and a catalytic Ullmann-type cyclization. This work is part of a larger effort to uncover new clinical candidates from the taccalonolide class of anticancer agents through advances in chemical synthesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28849658     DOI: 10.1021/acs.orglett.7b02349

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Recent Progress in Steroid Synthesis Triggered by the Emergence of New Catalytic Methods.

Authors:  Hem Raj Khatri; Nolan Carney; Ryan Rutkoski; Bijay Bhattarai; Pavel Nagorny
Journal:  European J Org Chem       Date:  2020-01-01

2.  Development of a Terpene Feedstock-Based Oxidative Synthetic Approach to the Illicium Sesquiterpenes.

Authors:  Kevin Hung; Matthew L Condakes; Luiz F T Novaes; Stephen J Harwood; Takahiro Morikawa; Zhi Yang; Thomas J Maimone
Journal:  J Am Chem Soc       Date:  2019-02-11       Impact factor: 15.419

3.  Synthesis and Biological Evaluations of Electrophilic Steroids Inspired by the Taccalonolides.

Authors:  Nicholas A Clanton; Shayne D Hastings; Griffin B Foultz; Julie A Contreras; Samantha S Yee; Hadi D Arman; April L Risinger; Doug E Frantz
Journal:  ACS Med Chem Lett       Date:  2020-11-20       Impact factor: 4.632

Review 4.  Taccalonolides: Structure, semi-synthesis, and biological activity.

Authors:  Yan Li; Yu-Feng Du; Feng Gao; Jin-Bu Xu; Ling-Li Zheng; Gang Liu; Yu Lei
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.